Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: A novel mechanism involved in 5-hydroxytryptamine-induced nociception: The indirect activation of primary afferents
Author: Tambeli, CH
Oliveira, MCG
Clemente, JT
Pelegrini-Da-Silva, A
Parada, CA
Abstract: The aim of this study was to test the hypothesis that 5-hydroxytryptamine induces nociception by an indirect action on the primary afferent nociceptor in addition to its previously described direct action. Injection of 5-hydroxytryptamine into the s.c. tissue of the hind paw of rats produced nociceptive flinch behavior and inflammatory cell migration, that were significantly reduced by the nonspecific selectin inhibitor fucoidan. 5-Hydroxytryptamine-induced nociception was also significantly reduced by local blockade of the 5-HT3 receptor by tropisetron, by the cyclooxygenase inhibitor indomethacin and by local blockade of the beta 1-adrenergic receptor or of the D1 receptor by atenolol or SCH 23390, respectively. Neither guanethidine depletion of norepinephrine in the sympathetic terminals nor local blockade of the beta 2-adrenergic receptor by ICI-118,551 significantly reduced 5-hydroxytryptamine-induced nociception. Taken together, these findings indicate that 5-hydroxytryptamine induces nociception by a novel, indirect and norepinephrine-independent mechanism mediated by neutrophil migration and local release of prostaglandin and dopamine. Furthermore, to test whether dopamine acts on beta 1-adrenergic and/or D1 receptor to contribute to 5-hydroxytryptamine-induced nociception, dopamine was s.c. injected either alone or combined with atenolol or with SCH 23390. S.c.-injected dopamine also produced a dose-dependent nociceptive behavior that was significantly reduced by both SCH 23390 and atenolol. Based on that it is proposed that dopamine, once released, activates D1 and beta 1-adrenergic receptors to contribute to 5-hydroxytryptamine-induced nociception. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.
Subject: serotonin
Country: Inglaterra
Editor: Pergamon-elsevier Science Ltd
Citation: Neuroscience. Pergamon-elsevier Science Ltd, v. 141, n. 3, n. 1517, n. 1524, 2006.
Rights: fechado
Identifier DOI: 10.1016/j.neuroscience.2006.04.030
Date Issue: 2006
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000239822800036.pdf447.77 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.